Oculogica Issued Patent for Biometric Identification Using an Eye Tracking System

Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics, announced today that the U.S. Patent and Trademark Office (USPTO) has issued the company a patent for a method of identifying patients using biometric information measured and captured by an eye tracking system. Identification of the patient may be performed by a cloud-based or local biometric service.

Oculogica Receives FDA Marketing Authorization for EyeBOX® Device, the First Non-Invasive, Baseline-Free Test for Concussion

FDA Grants Marketing Authorization for Use in Children 5 and Older and Adults up to 67 Years of Age. January 3, 2019 — NEW YORK– Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics, announced that the U.S. Food and Drug Administration (FDA) granted their De Novo request for the commercialization of the EyeBOX® device, the first non-invasive, …

Oculogica Receives FDA Marketing Authorization for EyeBOX® Device, the First Non-Invasive, Baseline-Free Test for Concussion Read More »

CHOP News: Are Eyes a Window to Diagnosing Acute Concussion in Youth?

There is a growing body of evidence that concussion can impair eye movement. During the past seven years, clinician-scientists at Children’s Hospital of Philadelphia’s (CHOP) Center for Injury Research and Prevention (CIRP) have evaluated the utility of a visio-vestibular exam to detect deficits in concussed pediatric and adolescent patients, and the use of automated eye tracking technology to objectively measure these deficits.

KARE: NFL Concussion Spotter: Eye Tracking Could Change Game

As the Vikings prepare to play the Saints in the playoffs, Hall of Fame quarterback Brett Favre is making news for his comments about the last time the two teams met in the 2009 playoffs, telling KFAN radio about what he considers an undiagnosed head injury.

Scroll to Top